Merck to focus on cancer immunotherapy, multiple sclerosis and infertility
Merck Korea, a Korean branch of Merch, the global life science company, announced a promise to lead the future industry by focusing on ‘cancer immunotherapy,’ ‘multiple sclerosis’ and ‘infertility’ in the pharmaceutical field.
On the 26th, Merck Korea held a press conference to celebrate the 350...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.